LIVERFASt™ IS REIMBURSED UNDER
CPT CODE: 0166U

LIVERFASt™ aids clinicians in the assessment of patients’ liver fibrosis, inflammatory activity and steatosis with one simple blood draw.

Medicare (Part B)

$0 out-of-pocket cost for the PLA.

Medicare Advantage

Typically $0 out of pocket for the PLA. Some plans have a coinsurance usually under $100.

Commercial Insurance

Plans vary, but you may be expected to cover a portion of the cost. Contact us at patientservices@dermtech.com to learn more about your coverage. High Deductible Plans If you are unsure that you have met your deductible, please contact us at service@fibronostics.com or your insurance directly.

High Deductible Plans

If you are unsure that you have met your deductible, please contact us at service@fibronostics.com or your insurance directly.

LIVERFASt™ is suitable for patients living with Non-Alcoholic Fatty Liver Disease (NAFLD) and Chronic Hepatitis B and Chronic Hepatitis C.

Prescribing LIVERFASt™ is simple and convenient.

prescribe liverfast

Physican prescribes LIVERFASt™ for the patients

prescribe liverfast

Patient has lab work done

prescribe liverfast

Using AI, biomarker results are combined with our proprietary algorithm to produce LIVERFASt™ results to customer portal

prescribe liverfast

Results are available fast

To learn more about integrating LIVERFASt™ in your organization